XML 176 R17.htm IDEA: XBRL DOCUMENT
v3.25.1

Measurement of financial assets and liabilities | 12 Months Ended
--- | ---
Dec. 31, 2024
Measurement of financial assets and liabilities |
Measurement of financial assets and liabilities | C2 Measurement of financial assets and liabilities The Group uses the trade date method to account for regular purchases and sales of financial assets. The Group holds financial assets in accordance with IFRS 9, whereby, subject to specific criteria, financial instruments are required to be accounted for under one of the following categories based on the way in which the assets are managed in order to generate cash flows and their contractual cash flow characteristics (whether the cash flows represent 'solely payments of principal and interest'):
– | Financial instruments at FVTPL: this comprises primarily instruments that are managed and the performance evaluated on a fair value basis, including liabilities related to net assets attributable to unit holders of consolidated investment funds and policyholder liabilities for investment contracts without DPF. In addition, this includes derivatives. All investments within this category are measured at fair value with all changes thereon being recognised in investment return in the income statement. An option is also available at initial recognition to irrevocably designate a financial instrument as at FVTPL if doing so eliminates or significantly reduces accounting mismatches. The vast majority of the financial investments of the Group are held at FVTPL.
– | Financial instruments at FVOCI under IFRS 9: these instruments are initially recognised at fair value plus attributable transaction costs and are subsequently measured at fair value. Interest and/or dividend income is recognised in the income statement. Unrealised gains and losses are recognised in other comprehensive income. Upon disposal or impairment based on the expected credit loss approach, accumulated unrealised gains and losses are transferred from other comprehensive income to the income statement as realised gains or losses except for equity securities that have been elected to be designated at FVOCI under IFRS 9, whereby there is no recycling to the profit or loss on derecognition.
– | Financial instruments at amortised cost: these instruments comprise non-quoted investments that have fixed or determinable payments, including loans collateralised by mortgages, deposits and other receivables. These investments are initially recognised at fair value plus transaction costs. Subsequently, these instruments are carried at amortised cost using the effective interest method. The effective interest rate is the rate that exactly discounts estimated future cash receipts through the expected life of the financial instrument or, when appropriate, a shorter period to the net carrying amount of the financial asset. When assets held at amortised cost are subject to impairment testing based on the expected credit loss approach, estimated future cash flows are compared to the carrying value of the asset. The estimated future cash flows are discounted using the financial asset’s original or variable effective interest rate and exclude credit losses that have not yet been incurred. If, in subsequent periods, an impaired loan or receivable recovers in value (in part or in full) and this recovery can be objectively related to an event occurring after the impairment, then any amount determined to have been recovered is reversed through the income statement.
C2.1 Determination of fair value The fair values of the financial instruments for which fair valuation is required under IFRS Standards are determined by the use of quoted market prices for exchange-quoted investments, or by using quotations from independent third parties, such as brokers and pricing services or by using appropriate valuation techniques. Climate change does not directly impact fair values particularly where these are built on observable inputs (ie level 1 and level 2), which represent the majority of the Group's financial instruments as discussed below. The estimated fair value of derivative financial instruments reflects the estimated amount the Group would receive or pay in an arm’s-length transaction. This amount is determined using quoted prices if exchange listed, quotations from independent third parties or valued internally using standard market practices. Valuation approach for level 2 fair valued assets and liabilities A significant proportion of the Group’s level 2 assets are private holdings, structured securities and other national and non-national government debt securities that are valued using observable inputs. These assets, in line with market practice, are generally valued using a designated independent pricing service or quote from third-party brokers. These valuations are subject to a number of monitoring controls, such as comparison to multiple pricing sources where available, monthly price variances, stale price reviews and variance analysis on prices achieved on subsequent trades. When prices are not available from pricing services, quotes are sourced directly from brokers. Prudential seeks to obtain a number of quotes from different brokers so as to obtain the most comprehensive information available on their executability. The selected quote is the one which best represents an executable quote for the security at the measurement date. Generally, no adjustment is made to the prices obtained from independent third parties. Adjustments are made in only limited circumstances, where it is determined that the third-party valuations obtained do not reflect fair value (eg either because the value is stale and/or the values are extremely diverse in range). Securities valued in such manner are classified as level 3 where these significant inputs are not based on observable market data. Valuation approach for level 3 fair valued assets and liabilities Investments valued using valuation techniques include financial investments which, by their nature, do not have an externally quoted price based on regular trades and financial investments for which markets are no longer active as a result of market conditions, eg market illiquidity. Level 3 assets of the Group consist primarily of property, infrastructure, private credit and private equity funds held by the participating funds and are externally valued using the net asset value of the invested entities. The Group’s valuation policies, procedures and analyses for instruments categorised as level 3 are overseen by business unit committees as part of the Group’s wider financial reporting governance processes. The procedures undertaken include approval of valuation methodologies, verification processes and resolution of significant or complex valuation issues. In addition, the Group has minimum standards for independent price verification to ensure valuation accuracy is regularly independently verified. Adherence to this policy is monitored across the business units. C2.2 Fair value measurement hierarchy
(a) | Assets and liabilities at fair value
All of the Group’s financial instruments held at fair value are classified as FVTPL at 31 December 2024 and measured on a recurring basis. In addition, at 31 December 2024, the Group classified certain assets and liabilities as held for sale as described in note C1.2 that have been measured at fair value on a non-recurring basis based on the expected sales proceeds for these businesses. The table below shows the assets and liabilities carried at fair value on a recurring basis analysed by level of the IFRS 13 ‘Fair Value Measurement’ defined fair value hierarchy. This hierarchy is based on the inputs to the fair value measurement and reflects the lowest level input that is significant to that measurement. Financial instruments at fair value ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 31 Dec 2024 $m |
​ | ​ | Level 1 | ​ | Level 2 | ​ | Level 3 | ​ | ​ |
​ |  | Quoted prices | ​ | Valuation based | ​ | Valuation based | ​ | ​ |
​ | ​ | (unadjusted) | ​ | on significant | ​ | on significant | ​ | ​ |
​ | ​ | in active | ​ | observable | ​ | unobservable | ​ | ​ |
​ |  | markets |  | market inputs |  | market inputs |  | Total |
​ |  | ​ |  | ​ |  | note (iii) |  | ​ |
Loans |  | – | ​ | 364 | ​ | – | ​ | 364 | ​
Equity securities and holdings in collective investment schemes |  | 72,574 | ​ | 5,311 | ​ | 3,117 | ​ | 81,002 | ​
Debt securities note (i) |  | 56,147 | ​ | 17,620 | ​ | 37 | ​ | 73,804 | ​
Derivative assets |  | 17 | ​ | 378 | ​ | – | ​ | 395 | ​
Derivative liabilities |  | (493) | ​ | (1,124) | ​ | – | ​ | (1,617) | ​
Total financial investments, net of derivative liabilities |  | 128,245 | ​ | 22,549 | ​ | 3,154 | ​ | 153,948 | ​
Investment contract liabilities without DPFnote (ii) |  | – | ​ | (748) | ​ | – | ​ | (748) | ​
Net asset value attributable to unit holders of consolidated investment funds |  | (2,679) | ​ | – | ​ | – | ​ | (2,679) | ​
Total financial instruments at fair value |  | 125,566 | ​ | 21,801 | ​ | 3,154 | ​ | 150,521 | ​
Percentage of total (%) | ​ | 83 | % | 15 | % | 2 | % | 100 | %
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 31 Dec 2023 $m |
​ | ​ | Level 1 | ​ | Level 2 | ​ | Level 3 | ​ | ​ |
​ | ​ | Quoted prices | ​ | Valuation based | ​ | Valuation based | ​ | ​ |
​ | ​ | (unadjusted) | ​ | on significant | ​ | on significant | ​ | ​ |
​ | ​ | in active | ​ | observable | ​ | unobservable | ​ | ​ |
​ |  | markets |  | market inputs |  | market inputs |  | Total |
​ |  | ​ |  | ​ |  | note (iii) |  | ​ |
Loans |  | – | ​ | 430 |  | – |  | 430 | ​
Equity securities and holdings in collective investment schemes |  | 56,327 | ​ | 5,562 |  | 2,864 |  | 64,753 | ​
Debt securities note (i) |  | 64,004 | ​ | 19,020 |  | 40 |  | 83,064 | ​
Derivative assets |  | 1,460 | ​ | 395 |  | – |  | 1,855 | ​
Derivative liabilities |  | (58) | ​ | (180) |  | – |  | (238) | ​
Total financial investments, net of derivative liabilities |  | 121,733 | ​ | 25,227 |  | 2,904 |  | 149,864 | ​
Investment contract liabilities without DPFnote (ii) |  | – | ​ | (769) |  | – |  | (769) |
Net asset value attributable to unit holders of consolidated investment funds |  | (2,711) | ​ | – |  | – |  | (2,711) |
Total financial instruments at fair value |  | 119,022 | ​ | 24,458 |  | 2,904 |  | 146,384 |
Percentage of total (%) | ​ | 81 | % | 17 | % | 2 | % | 100 | %
Notes
(i) | Of the total level 2 debt securities of $17,620 million at 31 December 2024 (31 December 2023: $19,020 million), $12 million (31 December 2023: $10 million) are valued internally.
(ii) | For Investment contract liabilities without DPF, it is assumed that these investment contracts are not quoted in an active market and do not have readily available published prices and that their fair values are determined using valuation techniques. It is assumed that all significant inputs used in the valuation are observable and these investment contract liabilities are classified in level 2.
(iii) | At 31 December 2024, the Group held $3,154 million (31 December 2023: $2,904 million) of net financial instruments at fair value within level 3. This represents 2 per cent (31 December 2023: 2 per cent) of the total fair valued financial assets, net of financial liabilities and comprises the following:
| – | Equity securities and holdings in collective investment schemes of $3,116 million (31 December 2023: $2,863 million) consisting primarily of property, infrastructure, private credit and private equity funds held by the participating funds, which are externally valued using the net asset value of the invested entities. Equity securities of $1 million (31 December 2023: $1 million ) are internally valued, representing less than 0.1 per cent of the total fair valued financial assets, net of financial liabilities. Internal valuations are inherently more subjective than external valuations; and
| – | Other sundry individual financial instruments of a net asset of $37 million(31 December 2023: $40 million).
| – | Of the net financial instruments of $3,154 million (31 December 2023: $2,904 million) referred to above:
| – | A net asset of $3,088 million (31 December 2023: $2,866 million) is held by the Group’s participating and unit-linked funds and therefore shareholders’ profit and equity are not immediately impacted by movements in the valuation of these financial instruments; and
| – | The remaining level 3 investments comprise a net asset of $66 million (31 December 2023: $38 million) and are primarily investments valued using external prices adjusted to reflect the specific known conditions relating to these holdings where applicable (eg distressed securities). If the value of all these level 3 financial instruments decreased by 10 per cent, the change in valuation would be $(7) million (31 December 2023: $(4) million), which would reduce shareholders’ equity by this amount before tax.
​ Transfers into and transfers out of levels The Group’s policy is to recognise transfers into and out of levels as of the end of each reporting period except for material transfers that are recognised as of the date of the event or change in circumstances that caused the transfer. Transfers are deemed to have occurred when there is a material change in the observed valuation inputs or a change in the level of trading activities of the securities. During 2024, the transfers between levels within the portfolios were primarily transfers from level 1 to level 2 of $940 million and transfers from level 2 to level 1 of $2,007 million. These transfers primarily reflect the change in the observed valuation inputs of equity securities and debt securities and, in certain cases, the change in the level of trading activities of the securities. There were no transfers from level 3 to level 2 and no transfer into level 3 in the year. Reconciliation of movements in level 3 assets and liabilities measured at fair value The following table reconciles the value of level 3 fair valued assets and liabilities at the beginning of the year to that presented at the end of the year. Total investment return recorded in the income statement represents interest and dividend income, realised gains and losses, unrealised gains and losses on the assets classified at fair value through profit and loss and foreign exchange movements on an individual entity’s overseas investments. Total gains and losses recorded in other comprehensive income comprises the translation of investments into the Group's presentation currency of US dollars. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2024 $m
​ | ​ | ​ | ​ | Equity | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | securities | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | and holdings | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | in collective | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | investment | ​ | Debt | ​ | ​
​ |  | Loans |  | schemes |  | securities |  | Group total
Balance at 1 Jan |  | – | ​ | 2,864 | ​ | 40 | ​ | 2,904
Total gain (loss) in income statement note |  | – | ​ | (84) | ​ | 3 | ​ | (81)
Total loss recorded in other comprehensive income |  | – |  | (31) |  | (1) |  | (32)
Purchases and other additions | ​ | – | ​ | 462 | ​ | 2 | ​ | 464
Sales | ​ | – | ​ | (94) | ​ | (7) | ​ | (101)
Balance at 31 Dec |  | – |  | 3,117 |  | 37 |  | 3,154
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 2023 $m
​ | ​ | ​ | ​ | Equity | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | securities | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | and holdings | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | in collective | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | investment | ​ | Debt | ​ | ​
​ |  | Loans |  | schemes |  | securities |  | Group total
Balance at 1 Jan |  | 3 |  | 824 |  | 38 |  | 865
Total gains in income statement note |  | – |  | 25 |  | 2 |  | 27
Total gains recorded in other comprehensive income |  | – |  | 6 |  | – |  | 6
Purchases and other additions |  | – |  | 524 |  | – |  | 524
Sales |  | (3) |  | (4) |  | – |  | (7)
Transfers into level 3 |  | – |  | 1,489 |  | – |  | 1,489
Balance at 31 Dec |  | – |  | 2,864 |  | 40 |  | 2,904
Note Of the total net (loss) gain in the income statement of $(81) million at 2024 (2023: $27 million), $(143) million (2023: $29 million) relates to net unrealised gain (loss) of financial instruments still held at the end of the year, which can be analysed as follows: ​
​ | ​ | ​ | ​ | ​
​ |  | 2024 $m |  | 2023 $m
Equity securities and holdings in collective investment schemes |  | (146) |  | 27
Debt securities |  | 3 |  | 2
Net unrealised (loss) gains of financial instruments still held at the end of the year |  | (143) |  | 29
​ ​
(b) | Assets and liabilities carried at amortised cost and their fair value
The table below shows the financial assets and liabilities carried at amortised cost on the statement of financial position and their fair value. Deposits, cash and cash equivalents, accrued investment income, other debtors, accruals, deferred income and other creditors are excluded from the analysis below, as these are carried at amortised cost which approximates fair value. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | 31 Dec 2024 $m |  | 31 Dec 2023 $m
​ | ​ | Carrying | ​ | Fair | ​ | Carrying | ​ | Fair
​ | ​ | value | ​ | value | ​ | value | ​ | value
​ |  | ​ |  | note (iii) |  | ​ |  | note(iii)
Financial assets | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Loans note (i) |  | 153 | ​ | 163 |  | 148 | ​ | 179
Financial liabilities | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Core structural borrowings of shareholder-financed businesses note (ii) |  | (3,925) | ​ | (3,694) |  | (3,933) | ​ | (3,659)
Operational borrowings (excluding lease liabilities) note (i) |  | (540) | ​ | (540) |  | (707) | ​ | (707)
Obligations under funding, securities lending and sale and repurchase agreements note (i) |  | (272) | ​ | (272) |  | (716) | ​ | (716)
Net financial liabilities at amortised cost | ​ | (4,584) | ​ | (4,343) | ​ | (5,208) | ​ | (4,903)
​ Notes
(i) | The fair value of loans, operational borrowings (excluding lease liabilities) and obligations under funding, securities lending and sale and repurchase agreements has been estimated from the discounted cash flows expected to be received or paid.
(ii) | The fair value of the subordinated and senior debt issued by the Group is determined using quoted prices from independent third parties.
(iii) | All financial assets and liabilities in the table above have been classified within level 2 at 31 December 2024 and 2023, reflecting the observability of the inputs used to derive their fair value.
C2.3 Additional information on financial instruments (a) Financial assets and liabilities by IFRS 9 category The following table presents measurement categories under IFRS 9 for each class of the Group’s financial assets and financial liabilities as shown on the Consolidated statement of financial position as at 31 December 2024 and 2023. ​
Financial instruments | Classification under IFRS 9
Financial assets | ​
Loans | Amortised cost (31 Dec 2024: $153 million; 31 Dec 2023: $148 million)
​ | Mandatorily at FVTPL (31 Dec 2024: $364 million; 31 Dec 2023: $430 million)
Equity securities and portfolio holdings in collective investment schemes | Mandatorily at FVTPL
Debt securities | Mandatorily at FVTPL
Derivative assets | Mandatorily at FVTPL
Accrued investment income | Amortised cost
Deposits | Amortised cost
Cash and cash equivalents | Amortised cost
Other debtors | Amortised cost
Financial liabilities | ​
Investment contract liabilities without DPF | Mandatorily at FVTPL
Derivative liabilities | Mandatorily at FVTPL
Core structural borrowings of shareholder-financed businesses | Amortised cost
Operational borrowings | Amortised cost
Obligations under funding, securities lending and sale and repurchase agreements | Amortised cost
Net asset value attributable to unit holders of consolidated investment funds note | Designated at FVTPL
Other liabilities | Amortised cost
​ Note Net asset value attributable to unit holders of consolidated investment funds represents the interests of investors other than the Group in the investment funds that the Group is deemed to control and therefore treated as a subsidiary and consolidated in the Group financial statements. The Group has designated Net asset value attributable to unit holders of consolidated investment funds as financial liabilities measured at FVTPL to eliminate any accounting mismatch with the underlying investments of those consolidated investment funds, which are measured at FVTPL. ​ (b) Financial risk Liquidity analysis The vast majority of the Group’s financial assets are held to back the Group’s policyholder liabilities. Although asset/liability matching is an important component of managing policyholder liabilities (both those classified as insurance and those classified as investments), this profile is mainly relevant for managing market risk rather than liquidity risk. Within each business unit, this asset/liability matching is performed on a portfolio-by-portfolio basis. In terms of liquidity risk, a large proportion of the policyholder liabilities contain discretionary surrender values or surrender charges, meaning that many of the Group’s liabilities are expected to be held for the long term.Much of the Group’s investment portfolios are in marketable securities, which can therefore be converted quickly to liquid assets. For the reasons provided above, an analysis of the Group’s assets by contractual maturity is not considered meaningful to evaluate the nature and extent of the Group’s liquidity risk. Contractual maturities of financial liabilities on an undiscounted cash flow basis The following table sets out the contractual maturities for applicable classes of financial liabilities, excluding derivative liabilities that are separately presented. The financial liabilities are included in the column relating to the contractual maturities of the undiscounted cash flows (including contractual interest payments) based on the earliest period in which the Group can be required to pay assuming conditions are consistent with those of year end. For investment contracts without DPF, the maturity profile is based on undiscounted cash flow projections of expected benefit payments. ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 31 Dec 2024 $m
​ | ​ | ​ | ​ | Contractual maturity profile for financial liabilities
​ | ​ | Total | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Total
​ | ​ | carrying | ​ | 1 year | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 10-15 | ​ | 15-20 | ​ | Over | ​ | No stated | ​ | undiscounted
​ |  | value |  | or less |  | 1-2 years |  | 2-5 years |  | 5-10 years |  | years |  | years |  | 20 years |  | maturity |  | cash flows
Investment contracts without DPF note | ​ | 748 | ​ | 186 | ​ | 9 | ​ | 69 | ​ | 114 | ​ | 19 | ​ | 7 | ​ | 4 | ​ | 360 | ​ | 768
Core structural borrowings of shareholder-financed businesses |  | 3,925 | ​ | 125 | ​ | 125 | ​ | 678 | ​ | 3,111 | ​ | – | ​ | – | ​ | – | ​ | 750 | ​ | 4,789
Lease liabilities under IFRS 16 | ​ | 257 | ​ | 84 | ​ | 71 | ​ | 111 | ​ | 18 | ​ | – | ​ | – | ​ | – | ​ | – | ​ | 284
Other operational borrowings |  | 540 | ​ | 540 | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | 540
Obligations under funding, securities lending and sale and repurchase agreements |  | 272 | ​ | 272 | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | 272
Accruals, deferred income and other liabilities |  | 2,848 | ​ | 2,641 | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | 265 | ​ | 2,906
Net asset value attributable to unit holders of consolidated investment funds |  | 2,679 | ​ | 2,679 | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | – | ​ | 2,679
Total non-derivative financial liabilities | ​ | 11,269 | ​ | 6,527 | ​ | 205 | ​ | 858 | ​ | 3,243 | ​ | 19 | ​ | 7 | ​ | 4 | ​ | 1,375 | ​ | 12,238
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 31 Dec 2023 $m
​ | ​ | ​ | ​ | Contractual maturity profile for financial liabilities
​ | ​ | Total | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | Total
​ | ​ | carrying | ​ | 1 year | ​ | ​ | ​ | ​ | ​ | ​ | ​ | 10-15 | ​ | 15-20 | ​ | Over | ​ | No stated | ​ | undiscounted
​ |  | value |  | or less |  | 1-2 years |  | 2-5 years |  | 5-10 years |  | years |  | years |  | 20 years |  | maturity |  | cash flows
Investment contracts without DPF note | ​ | 769 | ​ | 155 | ​ | 169 | ​ | 68 | ​ | 149 | ​ | 24 | ​ | 9 | ​ | 5 | ​ | 273 | ​ | 852
Core structural borrowings of shareholder-financed businesses |  | 3,933 |  | 126 |  | 126 | ​ | 379 |  | 3,555 |  | – |  | – |  | – |  | 750 |  | 4,936
Lease liabilities under IFRS 16 | ​ | 234 | ​ | 76 | ​ | 62 | ​ | 86 | ​ | 25 | ​ | 2 | ​ | – | ​ | – | ​ | – | ​ | 251
Other operational borrowings |  | 707 |  | 707 |  | – | ​ | – |  | – |  | – |  | – |  | – |  | – |  | 707
Obligations under funding, securities lending and sale and repurchase agreements |  | 716 |  | 716 |  | – | ​ | – |  | – |  | – |  | – |  | – |  | – |  | 716
Accruals, deferred income and other liabilities |  | 4,035 |  | 3,845 |  | – | ​ | – |  | – |  | – |  | – |  | – |  | 190 |  | 4,035
Net asset value attributable to unit holders of consolidated investment funds |  | 2,711 |  | 2,711 |  | – | ​ | – |  | – |  | – |  | – |  | – |  | – |  | 2,711
Total non-derivative financial liabilities |  | 13,105 |  | 8,336 |  | 357 | ​ | 533 |  | 3,729 |  | 26 |  | 9 |  | 5 |  | 1,213 |  | 14,208
​ Note The undiscounted cash flows of investment contracts without DPF included under the 'No stated maturity’ category in the maturity profile shown above are mostly repayable on demand due to most of these investment contracts having options to surrender early, though often subject to surrender or other penalties, therefore, these options are unlikely to be exercised in practice. ​ Maturity analysis of derivatives The following table shows the carrying value of the gross and net derivative positions. ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Carrying value of net derivatives $m
​ | ​ | ​ | ​ | ​ | ​ | Net
​ | ​ | Derivative | ​ | Derivative | ​ | derivative
​ |  | assets |  | liabilities |  | position
31 Dec 2024 |  | 395 | ​ | (1,617) | ​ | (1,222)
31 Dec 2023 |  | 1,855 | ​ | (238) | ​ | 1,617
​ All net derivatives are carried at fair value and are considered to be due within one year or less, representing the basis on which they are managed (ie to manage principally asset or liability value exposures). The Group has no cash flow hedges and, in general, contractual maturities are not considered essential for an understanding of the timing of the cash flows for these instruments. Credit risk The Group’s maximum exposure to credit risk of financial instruments before any allowance for collateral or allocation of losses to policyholders is represented by the carrying value of financial instruments on the balance sheet that have exposures to credit risk comprising cash and cash equivalents, deposits, debt securities, loans and derivative assets, accrued investment income and other debtors. Further details of collateral in place in relation to derivatives, securities lending, repurchase and reverse repurchase agreements and other transactions are provided in note (c) below. The Group’s exposure to credit risk is further discussed in the Risk review report. The majority of Group’s financial instruments are carried at FVTPL. The total value of assets held at amortised cost is $13,603 million (31 December 2023: $12,933 million), comprising primarily cash and cash equivalents, deposits and accrued investment income where the credit risk is considered to be low by nature. There are no material expected credit losses recognised on these assets. At 31 December 2024, there are immaterial amounts that are past their due date totalling $4 million (31 December 2023: $9 million). In addition, the Group did not take possession of any other collateral held as security in both years. Foreign exchange risk The Group is exposed to exchange gains and losses on financial assets and liabilities held by the Group’s business units in a currency other than the functional currency of the relevant business units or the currency to which the functional currency is pegged (eg financial assets and liabilities of USD - denominated business in Hong Kong). The exchange risks inherent in these exposures are mitigated through the use of derivatives, mainly forward currency contracts and currency swaps as described in note (c) below. The exchange gains (losses) on financial instruments, recognised in the income statement in 2024, except for those arising on financial instruments measured at FVTPL, is $(28) million (2023: $(38) million). (c) Derivatives and hedging Derivative financial instruments are used to reduce or manage investment, interest rate and currency exposures to facilitate efficient portfolio management and for investment purposes. The Group does not regularly seek to apply fair value or cash flow hedging treatment under IFRS 9. The Group has no net investment, fair value or cash flow hedges under IFRS 9 at 31 December 2024 and 2023, respectively. All derivatives that are not designated as hedging instruments are carried at fair value, with movements in fair value being recorded in the income statement. Derivatives held and their purpose The Group enters into a variety of exchange traded and over-the-counter derivative financial instruments, including futures, options, forward contracts, swaps and swaptions. All over-the-counter derivative transactions are conducted under standardised ISDA (International Swaps and Derivatives Association Inc) master agreements and collateral agreements are in place between the individual entities and relevant counterparties under each of these market master agreements. The collateral management for these transactions is conducted under the usual and customary terms and conditions set out in the Credit Support Annex to the ISDA master agreement. Derivatives are used for efficient portfolio management to obtain cost effective and management of exposure to various markets in accordance with the Group’s investment strategies and to manage exposure to interest rate, currency, credit and other business risks. The Group also uses interest rate derivatives to reduce exposure to interest rate volatility. (d) Derecognition, collateral and offsetting Derecognition of financial assets and liabilities The Group’s policy is to derecognise financial assets when it is deemed that substantially all the risks and rewards of ownership have been transferred. The Group derecognises financial liabilities only when the obligation specified in the contract is discharged, cancelled or has expired. Reverse repurchase agreements The Group is party to various reverse repurchase agreements under which securities are purchased from third parties with an obligation to resell the securities. The securities are not recognised as investments in the statement of financial position but the right to receive the cash paid is recognised as deposits. At 31 December 2024, the fair value of the collateral held in respect of reverse repurchase agreements, represented by the purchased securities, was $2,871 million (31 December 2023: $3,623 million). ​ Securities lending and repurchase agreements The Group is also party to various securities lending agreements (including repurchase agreements) under which securities are loaned to third parties on a short-term basis. The loaned securities are not derecognised; rather, they continue to be recognised within the appropriate investment classification. To the extent cash collateral is received it is recognised on the statement of financial position with the obligation to repay the cash paid recognised as a liability. Other collateral is not recognised. At 31 December 2024, the Group had $1,565 million (31 December 2023: $2,001 million) of lent securities and assets subject to repurchase agreements. The cash and securities collateral held or pledged under such agreements were $1,686 million (31 December 2023: $2,042 million). Collateral and pledges under derivative transactions At 31 December 2024, the Group had pledged $1,527 million (31 December 2023: $457 million) for liabilities and held collateral of $280 million (31 December 2023: $1,586 million) for assets in respect of derivative transactions. These transactions are conducted under terms that are usual and customary to collateralised transactions including, where relevant, standard securities lending and repurchase agreements. The Group has entered into collateral arrangements in relation to derivative transactions, which permit sale or re-pledging of underlying collateral. The Group has not sold any non-cash collateral held or re-pledged any non-cash collateral. Offsetting assets and liabilities The Group’s derivative instruments, repurchase agreements and securities lending agreements are subject to master netting arrangements and collateral arrangements. A master netting arrangement with a counterparty creates a right of offset for amounts due to and due from that same counterparty that is enforceable in the event of a default or bankruptcy. The Group recognises amounts subject to master netting arrangements on a gross basis within the consolidated balance sheets. The following tables present the gross and net information about the Group’s financial instruments subject to master netting arrangements: ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 31 Dec 2024 $m
​ | ​ | ​ | ​ | Related amounts not offset | ​ | ​
​ | ​ | Gross amount | ​ | in the balance sheet | ​ | ​
​ |  | included in the |  | ​ |  | ​ |  | ​ |  | Net amount
​ | ​ | balance | ​ | Financial | ​ | Cash | ​ | Securities | ​ | included in the
​ | ​ | sheet | ​ | instruments | ​ | collateral | ​ | collateral | ​ | balance sheet
​ | ​ | note (i) | ​ | note (ii) | ​ | ​ | ​ | note (iii) | ​ | note (iv)
Derivative assets |  | 376 | ​ | (106) | ​ | (267) | ​ | – | ​ | 3
Reverse repurchase agreements |  | 2,868 | ​ | – | ​ | – | ​ | (2,868) | ​ | –
Total financial assets |  | 3,244 | ​ | (106) | ​ | (267) | ​ | (2,868) | ​ | 3
Derivative liabilities |  | (1,597) | ​ | 106 | ​ | 512 | ​ | 927 | ​ | (52)
Securities lending and repurchase agreements |  | (272) | ​ | – | ​ | 43 | ​ | 228 | ​ | (1)
Total financial liabilities |  | (1,869) | ​ | 106 | ​ | 555 | ​ | 1,155 | ​ | (53)
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | 31 Dec 2023 $m
​ | ​ | ​ | ​ | Related amounts not offset | ​ | ​
​ | ​ | Gross amount | ​ | in the balance sheet | ​ | ​
​ |  | included in the |  | ​ |  | ​ |  | ​ |  | Net amount
​ | ​ | balance | ​ | Financial | ​ | Cash | ​ | Securities | ​ | included in the
​ | ​ | sheet | ​ | instruments | ​ | collateral | ​ | collateral | ​ | balance sheet
​ | ​ | note (i) | ​ | note (ii) | ​ | ​ | ​ | note (iii) | ​ | note (iv)
Derivative assets |  | 1,820 |  | (138) |  | (1,529) | ​ | (11) |  | 142
Reverse repurchase agreements |  | 3,616 |  | (12) |  | – |  | (3,604) |  | –
Total financial assets |  | 5,436 |  | (150) |  | (1,529) |  | (3,615) |  | 142
Derivative liabilities |  | (225) |  | 138 |  | 57 |  | – |  | (30)
Securities lending and repurchase agreements |  | (713) |  | – |  | (18) |  | 730 |  | (1)
Total financial liabilities |  | (938) |  | 138 |  | 39 |  | 730 |  | (31)
Notes
(i) | The Group has not offset any of the amounts included in the balance sheet.
(ii) | Represents the amount that could be offset under master netting or similar arrangements where the Group does not satisfy the full criteria to offset in the balance sheet.
(iii) | Excludes initial margin amounts for exchange-traded derivatives.
(iv) | In the tables above, the amounts of assets or liabilities included in the balance sheet would be offset first by financial instruments that have the right of offset under master netting or similar arrangements with any remaining amount reduced by the amount of cash and securities collateral. The actual amount of collateral may be greater than amounts presented in the tables.

X
- Definition The entire disclosure for fair value measurement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 13 -IssueDate 2024-01-01 -Section Disclosure -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS13_g91-99_TI -URIDate 2024-03-27 + Details
Name: | ifrs-full_DisclosureOfFairValueMeasurementExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | puk_DisclosureOfFairValueMeasurementAbstract
Namespace Prefix: | puk_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration